Large-scale genomics studies have failed to identify specific pathways that go awry in schizophrenia. Alternative approaches focusing on cellular, molecular and systems-level changes may be needed.

Mounting evidence illustrates how peripheral molecules can influence brain function, offering new therapeutic targets.